Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
Provided By PR Newswire
Last update: Jun 18, 2025
Lucid to partner with Hoag in its mission to eradicate esophageal cancer by expanding access to EsoGuard precancer testing across its extensive healthcare delivery network
Read more at prnewswire.com1.1
+0.05 (+4.76%)
0.4686
+0.05 (+11.33%)
Find more stocks in the Stock Screener
LUCD Latest News and Analysis
12 days ago - By: Chartmill
